UNH UnitedHealth Group
Margin repair has started, but a regulated 5.5% ceiling leaves the price still ahead of value.
The story
UnitedHealth is the largest US managed-care franchise, combining UnitedHealthcare's scale in insurance with Optum's vertically integrated care delivery, pharmacy benefits and data assets. The moat (scale, network density, data, integration) is intact, but the business is in a mature, regulated phase: Medicare Advantage rate pressure, elevated utilization, risk-adjustment scrutiny and Optum Health restructuring cut margins from about 9% to about 4%. TTM margin has ticked up to 4.7%, so a recovery has started, but repricing and regulation cap how far it can go.
I kept most drivers. The only change is a small move in target margin from 5.0% to 5.5% (about 10% relative, below the 20% threshold), with convergence in 6 years instead of 7, because TTM margin rose from 4.2% to 4.7% as 2026 repricing and benefit cuts took hold. The target stays well below the old 8 to 9% because regulatory and cost-trend headwinds look structural. Growth of 5.5% reflects deliberate membership shedding and pricing discipline, and sales-to-capital of 2.6 matches the observed 2.61.
Value drivers
| Revenue growth (Y1) | 5.5% |
| Terminal growth | 3.5% |
| Forecast horizon | 8y |
| Target operating margin | 5.5% |
| Years to target margin | 6 |
| Sales-to-capital | 2.60 |
| Beta | 1.05 |
| Failure probability | 3.0% |
| Cost of capital (WACC) | 9.3% |
| Terminal WACC | 9.1% |
Valuation bridge
| PV of explicit FCFF | 86.74B |
| PV of terminal value | 188.96B |
| Equity value | 207.66B |
| ÷ shares → per share | $231.35 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 474.89B | 5.5% | 4.9% | 20.14B | 9.52B | 10.62B | 9.72B |
| 2 | 499.65B | 5.2% | 5.0% | 21.74B | 9.52B | 12.22B | 10.23B |
| 3 | 524.27B | 4.9% | 5.1% | 23.39B | 9.47B | 13.92B | 10.67B |
| 4 | 548.61B | 4.6% | 5.2% | 25.08B | 9.36B | 15.72B | 11.03B |
| 5 | 572.52B | 4.4% | 5.4% | 26.81B | 9.19B | 17.61B | 11.31B |
| 6 | 595.83B | 4.1% | 5.5% | 28.56B | 8.97B | 19.59B | 11.51B |
| 7 | 618.38B | 3.8% | 5.5% | 29.64B | 8.68B | 20.96B | 11.27B |
| 8 | 640.03B | 3.5% | 5.5% | 30.67B | 8.32B | 22.35B | 11.00B |
Key risks
- CMS Medicare Advantage rate notices and risk-adjustment (V28/RADV) enforcement squeeze margins further
- DOJ investigations into MA billing and the Optum/UHC integration could force structural remedies
- Medical cost trend (utilization, specialty drugs, behavioral health) keeps outrunning premium repricing
Catalysts
- 2027 MA bids and final rate notice show margin repair holding through repricing
- Optum Health value-based care restructuring returns that segment to positive, growing margins